Xu Lin, Chen Shaohua, Li Chunmei, Zhou Xiaogang, Tang Li
Department of Science and Education, The First People's Hospital of Shuangliu District, Chengdu, People's Republic of China.
Department of Healthcare, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
Risk Manag Healthc Policy. 2024 Dec 11;17:3049-3063. doi: 10.2147/RMHP.S490301. eCollection 2024.
Despite the benefits of influenza vaccination, particularly for healthcare workers (HCWs) at higher risk, vaccination coverage among HCWs in China remains low. This study aims to provide updated insights into the knowledge, attitudes, practices, and barriers related to influenza vaccination among HCWs in China post-COVID-19 era, to inform strategies for improving vaccination rates and healthcare safety.
A cross-sectional survey was conducted between December 2023 and January 2024 at two tertiary hospitals in Chengdu, China. Logistic regression analyses were used to identify factors associated with HCWs' influenza vaccination uptake for the 2023-2024 season.
Of the 602 HCWs who completed the questionnaire (response rate: 86.0%), influenza vaccination uptake for the 2023-2024 season was low at 14.1%, down from 31.2% in 2021-2022 and 18.4% in 2022-2023. Main reasons for vaccine hesitancy included mistrust of vaccines (56.0%), inconvenient access (52.0%), and concerns over time, cost, and information (57.6%). Although most HCWs acknowledged the protective benefits of vaccination, only one-third supported mandatory vaccination, with concerns about personal autonomy among opponents. Multivariable logistic regression analysis showed that HCWs were more likely to be vaccinated if they believed it was essential for their job [adjusted odds ratio (aOR): 2.21; 95% confidence interval (CI): 1.13, 4.30), recognized their higher risk (aOR: 2.37; 95% CI: 1.09, 5.15), and were aware of high-risk groups for influenza vaccination (aOR: 2.49; 95% CI: 1.41, 4.40) as well as the age group with a higher infection rate (aOR: 1.89; 95% CI: 1.01, 3.51). However, those favoring increased campaign visibility had lower vaccination rates (aOR: 0.38; 95% CI: 0.17, 0.82).
The persistently low influenza vaccination rates among HCWs in China post-COVID-19 highlight significant gaps in healthcare risk management. Targeted interventions, including enhanced education and better vaccine access, are needed, along with further discussion on mandatory vaccination as a potential solution.
尽管流感疫苗接种有诸多益处,尤其是对风险较高的医护人员而言,但中国医护人员的疫苗接种率仍然较低。本研究旨在深入了解新冠疫情后中国医护人员在流感疫苗接种方面的知识、态度、行为及障碍,为提高接种率和医疗安全策略提供参考依据。
于2023年12月至2024年1月在中国成都的两家三级医院开展了一项横断面调查。采用逻辑回归分析来确定与医护人员2023 - 2024年度流感疫苗接种情况相关的因素。
在602名完成问卷的医护人员中(应答率:86.0%),2023 - 2024年度流感疫苗接种率较低,为14.1%,低于2021 - 2022年的31.2%和2022 - 2023年的18.4%。疫苗犹豫的主要原因包括对疫苗不信任(56.0%)、接种不便(52.0%)以及对时间、成本和信息的担忧(57.6%)。尽管大多数医护人员认可疫苗接种的保护作用,但只有三分之一的人支持强制接种,反对者担心个人自主权受到影响。多变量逻辑回归分析显示,如果医护人员认为接种对其工作至关重要(调整后的优势比[aOR]:2.21;95%置信区间[CI]:1.13,4.30) ),认识到自身风险较高(aOR:2.37;95% CI:1.09, 5.15),知晓流感疫苗接种的高危人群(aOR:2.49;95% CI:1.41, 4.40)以及感染率较高的年龄组(aOR:1.89;95% CI:1.01, 3.51),那么他们更有可能接种疫苗。然而,那些希望提高宣传力度的人接种率较低(aOR:0.38;95% CI:0.17, 0.82)。
新冠疫情后中国医护人员流感疫苗接种率持续偏低,凸显了医疗风险管理方面的重大差距。需要采取有针对性的干预措施,包括加强教育和改善疫苗可及性,同时进一步探讨将强制接种作为一种潜在解决方案。